Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Cash-and-Equivalents" stands at 19.82 Billion Hong Kong Dollars as of 06/30/2025, the highest value at least since 06/30/2011, the period currently displayed.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Cash and Equivalents" stands at 19.82 Billion HKD. This represents no change compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1,543.33 percent compared to the value the year prior.
The 1 year change in percent is 1,543.33.
The 3 year change in percent is 969.80.
The 5 year change in percent is 15.99.
The 10 year change in percent is 729.07.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Equivalents | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Equivalents | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Equivalents | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Equivalents | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Equivalents | 280,205,508,085.11 |